IGF2R Blood Levels May Help Predict Antibiotic Response in CF Pulmonary Exacerbations, Study Says
Measuring the levels of insulin-like growth factor 2 receptor (IGF2R) during the first days of treatment with intravenous antibiotics...
Proteostasis to Test Personalized Treatment with Novel CFTR Modulators in Europe
Three investigative therapies by Proteostasis Therapeutics — PTI-801, PTI-808, and PTI-428 — showed potential to treat cystic fibrosis...
Approval of drug therapy a 'new dawn' for cystic fibrosis care in Ireland
A drug which has the potential to treat the underlying cause of cystic fibrosis for 80% of patients in Ireland has been approved by the...
Medical News Today: Celiac disease may be treated with cystic fibrosis drugs
New research investigates the molecular similarities between celiac disease and cystic fibrosis. The results suggest that a compound...
New technology for protein bioconjugation and structural proteomics
Researchers at the Czech Academy of Sciences and the Brno-based start-up CF Plus Chemicals, a spin-off of ETH Zurich, has reported a new...
What are the benefits of NAC?
N-acetylcysteine (NAC) is a supplement that has been available for several decades. People take it for various reasons, including to help...
Israeli, US Researchers Develop New Device to Eliminate Mucus Secretion from Obstructed Airways
Researchers in Israel and the U.S. have developed a new technology that can be used to unclog and eliminate mucus secretions from the...
New Tool for Rapidly Analyzing CRISPR Edits Reveals Frequent Production of Unintended Edits
New method unmasks all DNA changes caused by CRISPR in two days vs two months WILMINGTON, DE — Amidst rising hopes for using CRISPR gene...
IGF2R Blood Levels May Help Predict Antibiotic Response in CF Pulmonary Exacerbations, Study Says
Measuring the levels of insulin-like growth factor 2 receptor (IGF2R) during the first days of treatment with intravenous antibiotics...
5 New Drug Approvals the FDA Gave Top Priority
The U.S. Food and Drug Administration's made it clear that granting a priority review to an application isn't exactly the same thing as...
